Publication | Open Access

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

ObesityMetabolic SyndromeWeight LossInsulin ManagementDiabetesPharmacologyClinical TrialsObesity ManagementInsulin HypersecretionInsulin DeliveryEndocrinologyMedicineInsulin SignalingDose-finding TrialHealth Sciences